Drug Shortage Report for BUTRANS 20

Last updated on 2022-05-31 History
Report ID 161051
Drug Identification Number 02341220
Brand name BUTRANS 20
Common or Proper name Buprenorphine Transdermal System
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) BUPRENORPHINE
Strength(s) 20MCG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 4
ATC code N02AE
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-05-19
Actual start date 2022-05-19
Estimated end date 2022-06-10
Actual end date 2022-05-30
Shortage status Resolved
Updated date 2022-05-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-05-20 English Compare
v2 2022-05-20 French Compare
v3 2022-05-30 English Compare
v4 2022-05-30 French Compare
v5 2022-05-31 English Compare

Showing 1 to 5 of 5